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Grape juicePolyphenols consumption detected in red wine and grape juice may prevent or help in the treatment of
hypertension. However, cardiovascular autonomic effects of polyphenols were poorly studied. Therefore,
we evaluated the effects of resveratrol and grape juice treatments in hemodynamics, baroreﬂex sensitiv-
ity, heart rate (HR) and blood pressure (BP) variability and cardiac redox parameters. Male Wistar rats
were divided in 3 groups (n = 7/each) and treated for 30 days: only L-NAME-treated (60 mg/kg/day by
oral gavage), L-NAME + resveratrol (L-NAME + R) and L-NAME + grape juice (L-NAME + G). BP signal
was directly recorded and pulse interval (PI) and systolic arterial pressure (SAP) variability were analyzed
in time and frequency domains. Baroreﬂex sensitivity (BRS) was determined by the alpha index. Oxidized
and reduced glutathione concentrations were determined in cardiac tissue. L-NAME increased BP with no
differences among groups (mean BP: L-NAME = 124 ± 4, L-NAME + R = 126 ± 3 and L-NAME + G =
125 ± 4 mmHg). PI and SAP variability expressed by total variance were also similar among groups.
However, normalized low frequency (LF) and high frequency (HF) components of PI variability were
lower and higher, respectively, in both R and G-treated groups when compared to only L-NAME group. In-
terestingly, sympathetic modulation to the vessels (LF from SAP variability) and BRS were decreased and
increased, respectively, only in L-NAME + R rats. Additionally, GSH/GSSG ratios were higher in
L-NAME + R and L-NAME + G than in L-NAME group. Our results indicate that resveratrol and grape
juice treatments can modulate autonomic function and promote cardiac redox beneﬁts even when nitric
oxide is decreased. Moreover, resveratrol inﬂuences not only cardiac but also vascular autonomic
modulation.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Hypertension is a clinical condition of high prevalence and difﬁ-
cult control. About 7.6 million deaths worldwide are attributable to
elevated blood pressure (BP) levels. Among the risk factors for
hypertension are age, gender, ethnicity, overweight, obesity, sedentary
lifestyle and unhealthy eating habits (WHO, 2009). Furthermore, for
each 20 mmHg increase in systolic BP (SBP) or 10 mmHg in diastolic
BP (DBP), the risk of mortality from ischemic heart disease and stroke
is doubled. On the other hand, a reduction of 5 mmHg in DBP and/or
10 mmHg in SBP may lower the risk of stroke by one-third and the
risk of coronary heart disease by one-sixth (Rosendorff et al., 2007).gre/RS. Tel.: +55 51 3303 8751.
rights reserved.Moreover, two dominants vasoactive systems, endothelium and
sympathetic nerves, seem to be important counterparts of blood pres-
sure regulation in hypertension. It has been also demonstrated in rats
that the inhibitory effect of L-NAME on endothelial function is entirely
reversed by the treatment with NO donors (Kristek, 2000; Török and
Kristek, 2002), Available data indicate that sympathetic overactivity
plays amajor role in the hypertension induced by chronic NO inhibition
(Kunes et al., 2004; Pechánová et al., 2004a; Zicha et al., 2006). Never-
theless, we have not found in the literature any study that well covers
the autonomic effects of grape juice and the association of these effects
with redox parameters.
Strategies for changing dietary habits and increasing the consump-
tion of polyphenols have been proposed to prevent or help the treat-
ment of hypertension. In this context, the antioxidant, anti-apoptotic
and anti-inﬂammatory properties of resveratrol, a polyphenol found in
red wine and grape juice (Romero-Pérez et al., 1999), have been inves-
tigated in many studies, as it seems to prevent endothelial dysfunction.
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found in male subjects who ingested grape juice for 8 weeks (Park et
al., 2004). In addition, in nephrectomized spontaneous hypertensive
rats, resveratrol consumption attenuated hypertension and prevented
endothelial nitric oxide synthase uncoupling. However, when these
rats were treated with resveratrol and L-NAME, the beneﬁts were no
longer observed (Bhatt et al, 2011).
In contrast, other studies have shown that red wine treatment
may prevent the increase in BP, cardiovascular remodeling and the
oxidative stress in L-NAME treated rats (Pechánová et al., 2004a,
2004b). Additionally, in rats with heart failure, resveratrol seems to
improve survival and attenuate systolic dysfunction and BP levels
(Wu et al., 2001).
These beneﬁts have been explained by the positive effect of res-
veratrol and other polyphenols on endothelial nitric oxide synthase
expression (Chu et al., 2011; Petrovski et al., 2011). However, other
mechanisms such as redox balance and autonomic modulation and
barorreﬂex sensitivity have been poorly explored.
The autonomic functional indexes such as heart rate variability,
systolic arterial pressure variability and baroreﬂex sensitivity (BRS)
have been regarded as important markers of mortality and organ
damage (La Rovere et al., 1998; Miao and Su, 2002). Indeed, the inter-
action between antioxidant enzymes, inﬂammatory conditions redox
parameters and autonomic nervous system has been shown in recent
studies (Zhang et al., 2010; Lee et al., 2011). Nevertheless, we have
not yet found any study that well covers the autonomic effects of
grape juice and the association of these effects with redox parameters.
Therefore, the aim of this studywas to evaluate the effects of resver-
atrol and grape juice treatments on oxidized and reduced glutathione in
cardiac tissue, BRS and cardiovascular autonomic modulation and
whether NO blockade interfere in these effects. The demonstration of
an improvement in these parameters would offer a new tool for early
prevention of cardiovascular disease.
2. Methods
2.1. Animals
Experiments were performed on male Wistar rats (251 ± 10 g),
with 12 weeks of age, from the Animal Shelter at Federal University
of Pelotas, Rio Grande do Sul, Brazil, receiving standard laboratory
chow and water ad libitum. The animals were housed in cages with
3 or 4 animals each in a temperature-controlled room (22 °C) with
a 12-h dark–light cycle. All surgical procedures and protocols used
were in accordance with the Guidelines for Ethical Care of Experi-
mental Animals approved by the International Animal Care and Use
Committee.
The rats were randomly assigned into 1 of 3 groups according to
the following treatments regimen (n = 7 each): control group
(only L-NAME), resveratrol (L-NAME + R) and grape juice treated
(L-NAME + G), all accompanied for 30 days. Concentrations of res-
veratrol were calculated in order to obtain the same proportion
found in grape juice (Wood CellarHouse®), and were established
after analyzing the juice composition. In this analysis, we deter-
mined the amount of 0.062 mg of resveratrol per 100 ml of juice.
The choice of the volume to be administered to the animals was de-
termined based on the beneﬁcial effects found in the daily intake of
500 ml of grape juice/day for a healthy individual. For the resveratrol
and grape juice treatments, 2 ml of the solutions were daily admin-
istered by gavage. L-NAME was diluted in ~1 mL of water and also
given by gavage (60 mg/kg/day).
2.2. Cardiovascular assessments
After the protocol period, 2 catheters ﬁlledwith 0.06 mL salinewere
implanted into the femoral artery and vein (PE-10) in anesthetizedanimals (Ketamine 80 mg/kg + Xylazine 12 mg/kg) for direct mea-
surements of BP.
Rats were studied 1 day after catheter placement; they were con-
scious and allowed to move freely during the experiments. An arterial
cannula was connected to a strain-gauge transducer (P23Db, Gould-
Statham, Oxnard, CA), and AP signals were recorded over a 30-minute
period by amicrocomputer equippedwith an analog-to-digital converter
board (Windaq, 2 kHz sampling frequency; Dataq Instruments, Inc.,
Akron,OH). The recorded data were analyzed on a beat-to-beat basis to
quantify changes in mean AP and heart rate (HR) (Farah et al., 1999;
Harthmann et al., 2007; Souza et al., 2007).2.3. Heart rate and blood pressure variabilities
Time-domain analysis consisted of calculating the variance from
pulse interval (PI) and systolic arterial blood pressure (SAP) respec-
tive time series. For frequency domain analysis, the whole 20-min
time series of PI and SAP were cubic-spline-interpolated (250 Hz)
and -decimated to be equally spaced in time. Following linear trend
removal, power spectral density was obtained by the autoregressive
method over 16,384 points with a Hanning window (512) and 50%
overlapping. Spectral power for very low- (VLF 0–0.20 Hz), low-
(LF 0.20–0.75 Hz), and high- (HF 0.75–3.0 Hz) frequency bands
was calculated by means of power spectrum density integration
within each frequency bandwidth, using a customized routine
(MATLAB 6.0, Mathworks) (Soares et al., 2004).
Given the fact that in freely moving animals the proportional
contribution of the very low frequency component may increase in
20-min-long recordings, data were also submitted to another pro-
cessing routine, where the 20-min recordings of the decimated PI sig-
nal (2048 points) were segmented in 2.5-min periods, and only
steady segments were processed as above described.
Spectral power within the low frequency component and high
frequency component bands in each animal along the 20-min recordings
were averaged across the 2.5-min segments and used for analysis (Soares
et al., 2004). The baroreﬂex sensitivity was evaluated by alpha index. The
alpha index analysis evaluates short-term changes in the systolic blood
pressure and in the PI interval. The coherence between the PI and the
SAP signal variability was assessed by means of a cross-spectral analysis.
The alpha index in the LF band was calculated only when the magnitude
of the squared coherence between the PI and SAP signals exceeded 0.5
(range, 0–1). After coherence calculation, the alpha index was obtained
from the square root of the ratio between PI and SAP variability in the
two major LF bands (Pagani et al., 1988).2.4. Determination of oxidized and reduced glutathione concentration
To determine oxidized and reduced glutathione concentrations,
cardiac tissue was deproteinized with 2 mol/L perchloric acid,
centrifuged for 10 min at 1000 g, and the supernatant was neutral-
ized with2 mol/L potassium hydroxide. The medium reaction
contained 100 mmol/L phosphate buffer (pH 7.2), 2 mmol/L nico-
tinamide dinucleotidephosphate acid, 0.2 U/mL glutathione reduc-
tase, and 70 μmol/L5,5′ dithiobis (2-nitrobenzoic acid). For the
determination of reduced glutathione,supernatant was neutralized
with 2 mol/l potassium hydroxide in order to react with 70 μmol/l
5,5′ dithiobis (2-nitro benzoicacid), and the absorbance values
were measured at 420 nm (Akerboom and Sies, 1981).2.4.1. Statistical analysis
Data are reported as means ± SEM, and ANOVA (one-way) was
used to compare groups, followed by the Student–Newman–Keuls
test. Pearson correlation was used to study the association between
variables.
Table 1
Hemodynamics variables in L-NAME, L-NAME + R and L-NAME + G groups.
Measurement/Group L-NAME L-NAME + R L-NAME + G
Systolic BP (mmHg) 174 ± 2 176 ± 3 173 ± 3
Diastolic BP (mmHg) 138 ± 3 141 ± 2 140 ± 4
Mean BP (mmHg) 124 ± 4 126 ± 3 125 ± 4
Heart rate (bpm) 380 ± 6 377 ± 9 382 ± 8
Results are shown inmean ± SEM. BP = blood pressure. R = resveratrol, G = grape juice.
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3.1. Hemodynamic evaluations
The direct BP evaluation performed at the end of the protocol was
not signiﬁcantly different among groups, as well as the HR (Table 1).
These results indicate that hemodynamic changes induced by
L-NAME treatment were not modiﬁed by resveratrol or grape juice
treatments.3.2. PI and SAP variabilities in time and frequency domains
The results of PI and SAP variabilities are presented in Fig. 1. The
PIV and SAPV in time domain expressed by variance were similar
among groups. Analyzed in the frequency domain, HR showed thatFig. 1. (A) Pulse interval variability (PIV) and systolic arterial pressure variability (SAPV). T
frequency domain among groups. (B)Normalized index of PIV in frequency domain and b
*p b 0.05 vs. L-NAME.absolute LF and absolute HF power components of PIV were similar
among groups. However, the normalized LF component of PIV was
lower in L-NAME + R and L-NAME + G when compared to the
L-NAME group. In addition, the normalized LF component of PIV
was similar between LNAME + R and LNAME + G groups. The HF
component of PIV was increased in L-NAME + R and L-NAME + G
in comparison with L-NAME. However, no signiﬁcant difference was
observed between normalized HF component of L-NAME + R and
L-NAME + G rats. Consequently, sympathovagal balance was signiﬁ-
cantly decreased in L-NAME + R and L-NAME + G groups when
compared to the L-NAME group. The LF component of SAPV was
lower in L-NAME + R than L-NAME group while L-NAME-G rats
were not different from L-NAME animals. Similarly, BRS (alpha
index) was improved only in L-NAME + R rats and no differences
were observed between L-NAME + G and L-NAME rats.
3.3. Cardiac redox parameters
GSSG values were lower in L-NAME + R (0.0023 ±
0.0008 mmol/gtec) and L-NAME + G (0.0026 ± 0.0008 mmol/gtec)
than in L-NAME (0.0052 ± 0.0005 mmol/gtec) group. However,
GSH values were similar among the groups L-NAME + G (0.10 ±
0.01 mmol/gtec), L-NAME + R (0.095 ± 0.011 mmol/gtec) and
L-NAME (0.08 ± 0.01 mmol/gtec). Consequently, GSH/GSSG ratios
were higher in L-NAME + R, (41 ± 5) and LNAME + G (39 ± 4)
than in L-NAME group (18 ± 3).here was no differences between PIV and SAPV in time domain and absolute values in
aroreﬂex index (alpha index) were altered after treatment. Results in mean ± SEM,
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Correlation was carried out by associating autonomic and cardiac
redox parameters (Fig. 2). A positive correlation was found between
GSH/GSSG ratio and PIV (r = 0.88 p = 0.0001). Additionally, a positive
correlation was found between GSH/GSSG and alpha index (0.73 p =
0.004). The sympathovagal balance and absolute LF component of
SAPV showed a negative correlation with GSH/GSSG (r = 0.7 p =
0.004 and r = 0.63 p = 0.01 respectively).
4. Discussion
The present study have shown that L-NAME rats undergoing res-
veratrol and grape juice treatments did not present any signiﬁcant
attenuation of hypertension compared to those which had not un-
dergone this treatment. However, resveratrol and grape juice treat-
ments promoted autonomic and oxidized and reduced glutathione
in cardiac tissue improvements. These results may be explained in
the light of other ﬁndings in the literature showing the positive ef-
fects of resveratrol and other polyphenols (Petrovski et al., 2011)
on endothelial nitric oxide synthase. In the present study, the ben-
eﬁts of the treatments might not be associated with these positive
effects, since all animals received L-NAME, a known blocker of the
isoforms of nitric oxide synthases. Moreover, resveratrol may act
on endothelial cells through different mechanisms, for instance,
the activation of Sirt 1 (silent mating type information regulation
2 homolog) and KLF2, (Krüppel-like factor 2), the phosphorylation
mediated by AMPK (adenosine monophosphate (AMP)-activated0
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of systolic arterial pressure variability), and D) LF/HF (sympathovagal balance).protein Kinase) and ERK1/2 (extracellular – signal-regulated kinase)
and by enhancing antioxidant enzymes expression and lowering reactive
oxygen species (Schmitt et al., 2010). In this context, and due to the inhi-
bition of NO, we believe that these other forms of resveratrol action may
partially account for our results in both treated groups, LNAME + R and
LNAME + G.
As far as we know, this is the ﬁrst study showing beneﬁcial effects
of resveratrol and grape juice in autonomic modulation. Our results
clearly demonstrate a decrease in sympathovagal balance in both
treated groups, and an additional decrease in SBP sympathetic modu-
lation and an increase in the alpha index only in resveratrol group.
This ﬁnding is relevant because several other studies have reported
that increased sympathetic modulation may lower BRS, and decrease
vagal modulation to the heart.
These effects could be associated not only to increases in both
mortality and morbidity, but also to the end organ damage (Miao
and Su, 2002; Mostarda et al., 2009; Mostarda et al., 2011). Therefore,
strategies which improve BRS, and as such, attenuate autonomic distur-
bance, can contribute to greater longevity and less target-organ damage
in hypertension.
The mechanisms by which resveratrol and grape juice would
promote these changes seem to be different, since sympathetic
modulation of SAP and BRS were improved only in L-NAME + R
group. Therefore we can hypothesize that while resveratrol acts in
both cardiac and vascular autonomic modulation, grape juice acts
primarily in cardiac modulation. Moreover, in our protocol no signif-
icant difference between GSH/GSSG ratio was observed in neither of
the treated groups. This result indicates that other changes in the0
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dismutase and thioredoxin may be related to these autonomic improve-
ments. Another possibility is the fact that resveratrol may attenuate auto-
nomicmodulationby reducing both the expression andactivity ofNADPH
oxidase (Spanier et al., 2009).
Indeed, it has been demonstrated that NADPH activation is associated
with increased sympathetic nervous systemmodulation in physiopatho-
logical conditions such as in central inﬂammation (Zhang et al., 2010).
Similarly, other researchers have suggested that xanthine oxidase inhibi-
tion promotes an increase in the left ventricular function, a decrease in
the catecholamine levels, an attenuation of arrhythmias and sympathetic
hiperinnervation in post infarcted hearts (Lee et al., 2011). The positive
correlation found between PIV with GSH/GSSG and baroreﬂex index
with GSH/GSSG reinforces this hypothesis. In fact, the negative correla-
tion between the sympathovagal balance and sympathetic modulation
with GSH/GSSG suggests an interaction between autonomic modulation
and cardiac redox parameters.
In conclusion, our results indicate that resveratrol and grape juice
treatment can promote cardiovascular and redox beneﬁts even when
the nitric oxide is decreased by the inhibition of nitric oxide synthase.
The additional improvement observed in sympathetic modulation to
the vessels (LF component of SAPV) in the rats treated only with res-
veratrol may be attributed to the improvement in BRS, which was
only observed in this group.References
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